MAZE holder plans sale of 22,500 shares

MAZE shareholder Atul Dandekar filed to sell up to 22,500 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an anticipated transaction date of 07/29/2026 on NASDAQ following an exercise of stock options for cash.

Accepted by SEC EDGAR 07/29/2026 - 04:18 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

MAZE shareholder Atul Dandekar filed to sell up to 22,500 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an anticipated transaction date of 07/29/2026 on NASDAQ following an exercise of stock options for cash. The filing also lists prior 10b5-1 sales of 7,500 shares on 06/29/2026 for $210,150.00 and 7,500 shares on 05/29/2026 for $197,553.75.

Key Figures

Planned shares to be sold: 22,500 shares Aggregate value of planned sale: $627,300.00 10b5-1 sale on 06/29/2026: 7,500 shares for $210,150.00 +2 more

5 metrics

Planned shares to be sold 22,500 shares Common stock listed with anticipated sale date 07/29/2026 on NASDAQ

Aggregate value of planned sale $627,300.00 Total value for 22,500 common shares to be sold

10b5-1 sale on 06/29/2026 7,500 shares for $210,150.00 Common stock sold under 10b5-1 plan during past three months

10b5-1 sale on 05/29/2026 7,500 shares for $197,553.75 Common stock sold under 10b5-1 plan during past three months

Brokerage firm Morgan Stanley Smith Barney LLC Executive Financial Services Handling the planned sale of 22,500 shares

Key Terms

10b5-1, Exercise of Stock Options, Executive Financial Services

3 terms

10b5-1 regulatory

"10b5-1 Sales for ATUL DANDEKAR 171 Oyster Point Blvd"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 07/29/2026 | Exercise of Stock Options | Issuer"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale is disclosed for MAZE in this Form 144 filing?

The filing discloses a planned sale of up to 22,500 shares of MAZE common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an anticipated transaction date of 07/29/2026 on NASDAQ following an exercise of stock options for cash.

What is the aggregate value of the planned MAZE share sale for 07/29/2026?

The planned sale of 22,500 shares of MAZE common stock has an aggregate value of $627,300.00. This amount is tied to the shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.

What recent 10b5-1 sales of MAZE shares did Atul Dandekar report?

Atul Dandekar reported 10b5-1 sales of 7,500 shares of MAZE common stock on 06/29/2026 for $210,150.00 and another 7,500 shares on 05/29/2026 for $197,553.75, both listed under sales during the past three months.

How are the MAZE shares in the Form 144 expected to be acquired before sale?

The MAZE shares are tied to an Exercise of Stock Options by the issuer, with the Form 144 indicating the acquisition method as stock option exercise and the payment method as cash before the planned sale of 22,500 shares.

Which broker is handling the planned MAZE share sale in this Form 144?

The planned sale of 22,500 MAZE shares is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as listed in the securities information section.

On which exchange are the MAZE shares in this Form 144 expected to trade?

The MAZE common shares covered by this Form 144 are listed with the trading market as NASDAQ. The planned sale of 22,500 shares is associated with that exchange in the securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002050167
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MAZE THERAPEUTICS, INC.
SEC File Number	001-42490
Address of Issuer	171 Oyster Point Blvd Suite 300 South San Francisco CALIFORNIA 94080
Phone	650-850-5070
Name of Person for Whose Account the Securities are To Be Sold	ATUL DANDEKAR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	22500	627300.00	55345261	07/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/29/2026	Exercise of Stock Options	Issuer			22500	07/29/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ATUL DANDEKAR 171 Oyster Point Blvd Suite 300 South San Francisco CA 94080	Common	06/29/2026	7500	210150.00
10b5-1 Sales for ATUL DANDEKAR 171 Oyster Point Blvd Suite 300 South San Francisco CA 94080	Common	05/29/2026	7500	197553.75

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	07/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Atul Dandekar
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)